Ci Private Wealth, LLC Akero Therapeutics, Inc. Put Options Transaction History
Ci Private Wealth, LLC
- $68.1 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
296Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$314 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$267 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$255 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$211 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.16B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...